It has been quite a year for the entire world, but it has been a defining year for life sciences companies. Under incredible pressure and a global microscope, the industry has come out more resilient and stronger than ever, thanks in large part to incredible talent. We see six trends that show how the immense growth ties to the right global workforce. Scientific breakthroughs continue to rise, R&D dollars surge The world’s biggest life sciences companies worked together this year like never before. In a unified race to find an effective Covid-19 vaccine, information sharing across usual boundaries was required to meet the public’s most pressing health crisis. Even before the pandemic took hold, research and development spend was up 22%. Then came greater demand for innovation and partnerships amid the pandemic. Increased investor risk and confidence Scientific breakthroughs have sustained investor enthusiasm for global life science companies. Global biopharma IPOs have raised more than $20 billion — each year bringing in more than in any previous year during the last decade, according to BioWorld data. In the first three quarters of 2019, early- and angel-/seed-stage investments accounted for around 60% of VC pharma and biotech deals, up from […]
